SARS-CoV-2 Spike Glycoprotein S1 Receptor Binding Domain [RBD] (319-541 aa)

Produktübersicht

• Artikelname: SARS-CoV-2 Spike Glycoprotein S1 Receptor Binding Domain [RBD] (319-541 aa)
• Artikelnummer: ABI-32-6269
• Hersteller Artikelnummer: 32-6269
• Alternativnummer: ABI-32-6269-5UG,ABI-32-6269-2UG
• Hersteller: Abeomics
• Kategorie: Proteine/Peptide
• Alternative Synonym: Coronavirus 2019 Spike Glycoprotein-S1 Receptor Binding Domain (319-541 a.a), Recombinant, sars-cov-2

Produktbeschreibung

Source: HEK293 Cells. A human infecting coronavirus (viral pneumonia) called 2019 novel coronavirus, 2019-nCoV was found in the fish market at the city of Wuhan, Hubei province of China on December 2019. The 2019-nCoV shares an 87% identity to the 2 bat-

Produkteigenschaften

• Reinheit: Protein is >90% pure as determined SDS-PAGE.
• Formel: nCoV-S1 RBD protein solution is supplied in 50mM sodium phosphate, pH7.5, 0.3M NaCl and 0.15M imidazole..

Anwendungsbeschreibung

• Application Verdünnung: SARS CoV-2 Spike Glycoprotein S1 RBD was tested for its biological functionality by its binding to recombinant ACE2 receptor protein confirmed by structural complementation reporter assay (NanoBiT).